U.S. License Holder:
Date of License:
XEOMIN (incobotulinumtoxinA) is an acetylcholine release inhibitor and neuromuscular blocking agent indicated for the treatment or improvement of adult patients with:
Upper limb spasticity;
Blepharospasm with onabotulinumtoxinA (Botox) prior treatment;
Temporary improvement in the appearance of moderate to severe glabellar lines with corrugator and/or procerus muscle activity.